Jim Wilson (WuXi Global Forum at JPM20)
November 12, 2020 09:26 AM ESTUpdated 11:59 AM
R&D
Cell/Gene Tx

Jim Wil­son of­fers a safer so­lu­tion to some of the in­dus­try's gene ther­a­py woes

Jason Mast

Editor

Jim Wil­son has been warn­ing for a while about the dan­gers of the vi­ral vec­tors used in most gene ther­a­pies. Two years ago he …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Can Bill An­der­son save Bay­er?

Verve is lat­est gene edit­ing com­pa­ny to suf­fer set­back, as Ver­tex walks away from pact

Drug pol­i­cy vet­er­an at CMS to de­part on Fri­day

CDC is in­ves­ti­gat­ing five hos­pi­tal­iza­tions af­ter use of Val­ne­va’s chikun­gun­ya vac­cine

FDA meet­ing to pick next win­ter's flu shot is can­celed, in omi­nous sign for US vac­cine pol­i­cy

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times